0.51 USD
↗ 0.02 (4.21%)PRE MARKET (AS OF 05:03 AM EDT)
Propanc Biopharma, Inc. Common Stock
PPCBNASDAQ • USD
Market: OPEN
PPCB is currently priced at $0.51. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 6, 2026.
Open?$0.51
High?$0.53
Low?$0.51
Prev. Close?$0.49
Volume?2.0K
Avg. Volume?3.6M
VWAP?$0.51
Rel. Volume?0.00x
Bid / Ask
Bid?$0.43 × 100
Ask?$0.56 × 400
Spread?$0.12
Midpoint?$0.49
Valuation & Ratios
Market Cap?4.8M
Shares Out?3.5M
Float?2.5M
Float %?71.3%
P/E Ratio?N/A
P/B Ratio?0.51
EPS?-$2.01
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Themes
Address
302/6 BUTLER STREET
CAMBERWELL, VICTORIA, C3 3124
Phone: 61-03-9882-0780
CAMBERWELL, VICTORIA, C3 3124
Phone: 61-03-9882-0780
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?100
Piotroski F-Score?0/9Weak
Altman Z-Score?-19.18Distress
Confidence?23%Very Low
Short InterestLow
Short % of Float?1.16%Low
Short Interest?29.0K
Days to Cover?1.0
Free Float2.5M
Avg Daily Volume298.2K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.55Strong
Quick Ratio?2.55Strong
Cash Ratio?0.25Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.51CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-210.6%WEAK▾
S&P3
ROA?-154.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-5687568
Enterprise Value?$4.0M
Fundamentals ratios updated end of day